Publications by authors named "M O Balogun"
Nanoparticle-based therapies represent a transformative approach to managing gynecological cancers, offering targeted treatment strategies that minimize harm to healthy tissues while maximizing therapeutic efficacy. Despite their potential, implementing these advanced treatments in Africa is needed by a complex interplay of technological, economic, regulatory, and ethical challenges. This paper examines the current landscape of nanoparticle-based therapies, identifying critical barriers to their adoption, including inadequate infrastructure, high costs, and insufficient regulatory frameworks.
View Article and Find Full Text PDFArticle Synopsis
- Viral suppression is crucial for ending the HIV epidemic, yet youth living with HIV in Nigeria experience lower rates of viral suppression compared to adults; a study aimed to identify risk factors contributing to this issue.
- Out of 541 participants, 40% were found to be non-suppressed; significant risk factors included substance use, missed medication doses, and self-reported barriers to taking medication, while being on a first-line regimen and having supportive social networks reduced these risks.
- The findings highlight the importance of addressing psychosocial behaviors and medication adherence in youth with HIV to improve viral suppression rates and ultimately achieve ART goals.
HPV vaccine knowledge, attitude, and programme satisfaction among parents and caregivers of vaccine recipients in Ogun state Nigeria.
Reprod Health
December 2024
Introduction: Human Papillomavirus is responsible for about 5% of the global cancer burden. In Nigeria, cervical cancer is the second most common cancer among women. The Federal Government of Nigeria and partners recently introduced Human Papillomavirus (HPV) vaccination into routine immunization beginning with 15 States and the Federal Capital Territory.
View Article and Find Full Text PDFArticle Synopsis
- A new iron-based electrocatalyst, nitrogen-doped FeMoO/MoN on nickel foam (NF@FMO/MN), has been developed for efficient hydrogen production in alkaline freshwater and seawater electrolysis.
- This catalyst achieves impressive low overpotentials of 23/29 mV at 10 mA/cm² and 112/159 mV at 100 mA/cm², outperforming the standard FeMoO catalyst.
- The enhanced performance is due to the catalyst's ability to lower water activation energy and improve water dissociation and hydrogen adsorption rates, making it a promising advancement in the field of electrocatalysis.